trending Market Intelligence /marketintelligence/en/news-insights/trending/IuIFGFRbGOm2wDe9vDSB4A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Taro Pharmaceutical repurchases $25.5M of ordinary shares

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Taro Pharmaceutical repurchases $25.5M of ordinary shares

Taro Pharmaceutical Industries Ltd. purchased $25.5 million of ordinary shares in its tender offer to buy back up to $225 million of the shares.

The Israel-based pharmaceutical company bought 280,719 shares at $91 apiece.

The shares represent 0.73% of the company's issued and outstanding shares as of the offer's close on Dec. 16.

American Stock Transfer & Trust Co. LLC, as the depositary, will immediately pay for the shares accepted for purchase and return the rest.

J.P. Morgan Securities LLC acted as the dealer manager for the tender offer, while MacKenzie Partners Inc. acted as the information agent.